Search results
350 results found
A much needed call to action – the launch of the Global Heat Health Resilience statementBlogThe consensus statement, initiated by the Physiological Society, calls on governments to recognise the challenge that rising temperatures are presenting to human health.
Regulating Advanced Therapy Medicinal Products in the UK after BrexitPolicy briefingAdvanced Therapy Medicinal Products offers new opportunities in treatment and intervention for diseases but it is not without challenges.
How do we close the diversity gap in genomics?BlogPHG policy analysts Tanya Brigden and Bhavya Krishnan bring perspectives from their respective fields to discuss how to close the diversity gap
Dr Zoë FritzZoë's research is focused on identifying areas of clinical practice that raise ethical questions and applying rigorous empirical and ethical analysis to explore the issues and find effective solutions.
Antisense oligonucleotides: new therapies for n = 1 rare diseasesBlogSome of diseases are so rare that only a single case (n = 1) or a few cases (n = few) are known globally. Therefore, rare disease patients need highly individualised treatments. Antisense oligonucleotides promise hope
Viral Genetic Surveillance, the canary in the coal mine for emerging diseases – a look at avian fluBlogWith the current pandemic of bird flu there is a growing concern around diseases spilling over from animals to humans.
Electrogenetic systems for type 1 diabetesBlogThere is a new field of research in synthetic biology called ‘electrogenetics’ that is exploring the use of tiny medical devices containing specially designed insulin-producing cells to help patients manage type 1 diabetes.
Informing the NHS 10 year planBlogWe are planning to convene an online event on 22 November to inform a contribution to the NHS ten year plan consultation. Find out more here.